Frontlight ResearchEarly access
What researchers published on Acute myeloid leukaemia
4,432 papers, newest first.
Showing 140 of 4,432
Elevated Allele Frequency of a Common Germline PDCD1 Variant Associated with Leukocytosis and Thrombocytopenia in Acute Myeloid Leukemia Treated with HDCT/ASCT.Cancers
ReviewAcute myeloid leukemia with TP53 mutation: molecular mechanisms and therapeutic advances.Leukemia & lymphoma
Systematic Characterization of AML Cell Lines to Support Preclinical In Vitro CAR-T Research.Cells
Monitoring of (Potentially Leukemia-Specific) Immune Cells After AML Relapse Post-Transplantation Across Treatment Groups and Disease Stages.Cancers
ReviewMaintenance Therapy After Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia: Still an Open Question?Cancers
ReviewAML Metabolism: A Dynamic Continuum of Functional Dependencies.Cells
Long-Term Survival of Patients with Relapsed/Refractory Acute Leukemia Receiving Clofarabine/Cyclophosphamide Prior to Hematopoietic Stem Cell Transplantation.Cancers
Case reportNursing Care Using Gordon's Model in Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia: A Case Report.Healthcare (Basel, Switzerland)
Acute Myeloid Leukemia in a Patient with Fontan Circulation - Case Report.Progress in pediatric cardiology
Optimizing Reduced-Intensity Conditioning for Older Patients with AML and MDS: A Large-Scale Analysis from the CIBMTR.Blood
ILA-producing Lacticaseibacillus paracasei NCU-21 exerts anti-acute myeloid leukemia effects by inhibiting the PI3K-AKT pathway.Genome biology
Integrated multi-omics reveals methylation-linked biological heterogeneity in intermediate-risk pediatric acute myeloid leukemia.iScience
Low-dose 10-day decitabine plus venetoclax induced rapid MRD negativity and durable remission in De Novo AML.Annals of hematology
Idarubicin synergistically enhances NK cell-mediated cytotoxicity by upregulating the AML cell surface ligand ULBP2.Leukemia research
FeDx-SF@βE assembly for AML treatment via GATA1/SLC40A1 pathway-mediated iron homeostasis disorder.Journal of nanobiotechnology
Specimen-Wise Evaluation of Acute Leukemia Subtyping Using Microscopic Hyperspectral Imaging.Photodiagnosis and photodynamic therapy
Miao medicine Xinlikang capsule attenuates acute erythroleukemia through immune regulation and FLI1-PI3K axis-mediated cell cycle arrest.Journal of ethnopharmacology
Two Immune States in Ex Vivo Venetoclax-Resistant AML: Antigen- Presentation Silencing versus Checkpoint Exhaustion.Current cancer drug targets
Retraction: Dickkopf 2 serves as a novel therapeutic target and prognostic biomarker in acute myeloid leukemia targeted by evodiamine.Frontiers in medicine
Precision Survival Estimation in Acute Myeloid Leukemia Using Evolutionary Learning-Derived microRNA Signature.Computational and structural biotechnology journal
Modulation of the RNA-sensing RIG/MAVS pathway bypasses resistance to hypomethylating agents in acute myeloid leukemia.HemaSphere
Allogeneic CD33/CD123 CAR-T сells in pediatric relapsed/refractory AML: early single-center experience.Transplantation and cellular therapy
New Phenazine 5,10-Dioxide Carbamates Inspired by Iodinin and Myxin Exhibit Improved Potency in Human Leukemia Cells with High Cytotoxic Selectivity, Activity against Mycobacterium Tuberculosis and Low Toxicity to Zebrafish Larvae.Journal of medicinal chemistry
Response to: Reassessing real-world FLT3 inhibitor maintenance patterns after allogeneic transplantation in acute myeloid leukemia.Journal of geriatric oncology
Exploring Efficacy and Predictors of Response to Venetoclax and Hypomethylating Agents in Newly Diagnosed Acute Myeloid Leukemia: A Real-World Study.International journal of cancer
Allogeneic hematopoietic stem cell transplantation is associated with improved long-term survival and molecular MRD clearance in KMT2A-altered AML.Annals of medicine
Teclistamab in multiple myeloma with coexisting myelodysplastic syndrome or acute myeloid leukemia.Haematologica
Discovery of Novel Pyridine-Dihydropyrrolo[3,4-b]Pyrrolidone Derivatives as Orally Active PIM Kinase Inhibitors for the Treatment of Acute Myeloid Leukemia.Journal of medicinal chemistry
Observational studyPaediatric Bone Marrow Transplant Outcomes.Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
Outcomes of Venetoclax-Based Regimens Versus Intensive and Reduced-Intensity Chemotherapy in Newly Diagnosed AML.Cancer medicine
Proceedings of the 2025 society for Hematopathology/European association for Haematopathology workshop session 1: new entities in pediatric acute leukemia.Journal of hematopathology
Differentiation hierarchy in adult B-cell acute lymphoblastic leukemia at clonal resolution.Leukemia
A Rare 18F-FDG PET/CT Finding Mimicking Leukemia Cutis in Acute Myeloid Leukemia: Palisaded Neutrophilic Granulomatous Dermatitis.Clinical nuclear medicine
Disease biology rather than donor type determines transplant outcomes in KMT2A-rearranged AML.Annals of hematology
Case reportPulmonary embolism as the initial manifestation of acute promyelocytic leukemia: A case report and review of the literature.Medicine
Next-Generation Sequencing in Acute Myeloid Leukemia: Advancing Clinical Insights.Anti-cancer agents in medicinal chemistry
Reassessing real-world FLT3 inhibitor maintenance patterns after allogeneic transplantation in acute myeloid leukemia.Journal of geriatric oncology
Neither the pan-immune-inflammation value nor the PILE score improved on APACHE-II or SOFA in a single-center cohort of critically ill older patients with acute myeloid leukemia.Frontiers in medicine
NPM1-mutated AML: One entity, multiple layers of heterogeneity.British journal of haematology
Mediator kinase inhibition exposes a transcriptional vulnerability and synergizes with venetoclax in AML.Leukemia
Diagnostic agreement between ChatGPT-based interpretation of laboratory-generated flow cytometry graphical outputs and hematologist consensus in suspected acute leukemia.Cytometry. Part B, Clinical cytometry
Expression patterns of hypoxia signaling pathway genes and their association with clinical biochemical parameters in acute myeloid leukemia patients of Assam: A case control study.Molecular biology reports
Occurrence of FLT3 mutations in acute myeloid leukemia and comparison of different methodologies.BMC cancer
Evolutionary dynamics in the years preceding acute myeloid leukaemia.Nature
Dual epigenetic agents combined with venetoclax and CAG regimen as induction therapy in newly diagnosed ELN 2022 adverse-risk AML.Clinical epigenetics
Rare variants of NPM1 mutations share a similar molecular background to the common NPM1 type A variant and are associated with similar survival in adults with acute myeloid leukaemia.British journal of haematology
Phenanthridone derivative PTD031 exerts efficacy against acute myeloid leukemia through dual targeting of DNA and redox homeostasis.Bioorganic chemistry
BCR::ABL1 emergence during menin inhibitor therapy in two patients with relapsed or refractory acute myeloid leukemia.Leukemia & lymphoma
How I treat MDS/AML: individualizing therapy based on disease biology, patient fitness, molecular features, and treatment goals.Clinical advances in hematology & oncology : H&O
ReviewAdvances in CBFA2T3::GLIS2 fusion gene in pediatric acute myeloid leukemia: from molecular mechanisms to targeted therapeutic strategies.Annals of hematology
ADGRE2: A Promising Immunotherapeutic Target in Acute Myeloid Leukemia and Chronic Myelomonocytic Leukemia.Cancer medicine
Lessons and limitations of the PARADIGM trial in acute myeloid leukemia.Clinical advances in hematology & oncology : H&O
Case reportCutaneous polyarteritis nodosa preceding acute myeloid leukemia with plasmacytoid dendritic cell differentiation and leukemia cutis.JAAD case reports
Safety and feasibility of peripherally inserted central catheter (PICC) placement in patients with newly diagnosed acute leukemia: A single-center retrospective study.Annals of hematology
Meta-analysisEfficacy and safety of the cladribine, idarubicin, and cytarabine regimen for treating acute myeloid leukemia: a systematic review and single-arm meta-analysis.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences
In plain wordsRead moreRead the paper on PubMedDifferential regulation of PRSS57 by tyrosine kinase inhibitors and ATRA in myeloid leukaemia cells: an in vitro study.Journal of applied genetics
ReviewSafety and efficacy of immune checkpoint inhibitors and hypomethylating agents in treatment-naïve AML and HR-MDS: a systematic review and HR-MDS meta-analysis.Cancer treatment and research communications
Review[Treatment of acute myeloid leukemia in older adults].[Rinsho ketsueki] The Japanese journal of clinical hematology
Luteolin reduces cytarabine-resistant acute myeloid leukemia cell proliferation through the GSK3β/Nrf2 pathway.Cytotechnology
Risk of subsequent primary acute myeloid leukemia after breast cancer: A population-based analysis of 608,268 women in the SEER Program.Leukemia research
TMEM150C and F2R as transcriptomic signatures for refractoriness to 7 + 3 induction therapy in acute myeloid leukemia.Frontiers in oncology
ReviewSRSF2-mutated acute myeloid leukemia: Mechanisms, clonal evolution, prognostic reappraisal, and emerging precision therapeutics.Leukemia research
Case reportRare primary bilateral ovarian myeloid sarcoma preceding acute myeloid leukemia: ovarian-sparing management with long-term ovarian function and pregnancy after allogeneic hematopoietic stem cell transplantation-a case report.AJOG global reports
Risk-Adapted Donor Selection in Patients with Acute Myeloid Leukemia.Transplantation and cellular therapy
ReviewEnvironmental risk factors for acute myeloid leukemia in adults, a systematic review.Blood reviews
Investigation of the expression profile of enhancer RNAs in acute myeloid leukemia based on RNA sequencing analysis.International journal of molecular and cellular medicine
ACTR5 as a potential therapeutic target in AML: Preliminary mechanistic insights from integrated multi-omics analysis.Cancer treatment and research communications
FDX1 suppresses acute myeloid leukemia progression and reverses cuproptosis resistance via the ROS/p53/ME1 axis.iScience
Complex and Cryptic KMT2A::MLLT10 Rearrangements in Acute Myeloid Leukemia Resolved by Optical Genome Mapping.Genes, chromosomes & cancer
Prediction of overall survival in acute myeloid leukemia using supervised machine learning.ESMO real world data and digital oncology
ReviewComplete remission in older acute myeloid leukemia: when does it really matter?Expert review of hematology
Performance Evaluation and Validation of a Next-Generation Sequencing-Based Measurable Residual Disease Assay for FLT3 Internal Tandem Duplication Detection in Acute Myeloid Leukemia.Annals of laboratory medicine
Case reportAcute myeloid leukemia following icotinib therapy for non-small cell lung cancer: a case report and literature review.Frontiers in oncology
MicroRNA-155-5p-dependent upregulation of PDCD4 is involved in oridonin-induced proliferation inhibition of leukemia cells.Oncology letters
Decitabine promotes PANX2 m6A modification and ferroptosis in acute myeloid leukemia.Epigenomics
Salvage-free, transplantation-free survival: a proposal for a new clinical endpoint in acute myeloid leukemia.Haematologica
Distinct clinical and molecular profiles of acute myeloid leukemia defined by mutations in IDH1, IDH2, and TET2.Haematologica
Case reportExploring the Impact of Nurse-Led Narrative Interviews on Newly Diagnosed Patients With Hematologic Disease: A Holistic Qualitative Case Study.Oncology nursing forum
Correction: T-cell replete haploidentical transplantation compared to mismatched unrelated allogeneic transplantation with post-transplantation cyclophosphamide in patients with secondary acute myeloid leukemia in first complete remission: a study from the ALWP/EBMT.Bone marrow transplantation
Clinical Study Protocol for PENTILULA: A Phase 1/2 Study Assessing [177Lu]Lu-Pentixather for Relapsed or Refractory CXCR4-Positive Acute Leukemia.Journal of nuclear medicine : official publication, Society of Nuclear Medicine
BCL11B-activated pediatric acute myeloid leukemia: a high-risk disease with frequent induction failure.Haematologica
Epigenetically activating T cells to attack AML.Blood
Molecular and clinical profiling of SF3B1, U2AF1, and SRSF2 mutations in Iranian patients with myelodysplastic neoplasms.Molecular biology reports
Integrated single-cell and bulk transcriptomic profiling reveals coagulation-associated heterogeneity and prognostic SPINT2 in acute myeloid leukemia.Frontiers in cell and developmental biology
ReviewOral DNA Demethylating Agents and Epigenetic Targeting in Adult T-Cell Leukemia/Lymphoma.Oncology research
Frequent FLT3 and IDH co-mutations in acute myeloid leukemia with mutated NPM1, NUP98 rearrangement, and KMT2A partial tandem duplication but not rearrangement: potential for combined targeted therapy.Haematologica
Tyrosine kinase inhibitors are associated with reduced AML transformation in systemic mastocytosis with myeloid neoplasm.Blood
Reply to: "Interpreting the Association Between Plasma Citrulline and Bloodstream Infection in Pediatric Acute Myeloid Leukemia".European journal of haematology
Aptamers in cancer research: Focus on leukemia.Chinese medical journal
A novel SLTM::RUNX1 acquired during CML progression and the clinical significance of concurrent BCR::ABL1 and RUNX1 rearrangements in Ph-positive leukemia.Cancer genetics
Overall Survival in Adults With Acute Myeloid Leukemia Initiating Quizartinib vs Midostaurin With Chemotherapy.JAMA network open
Corrigendum to Reduction in Disparate Access to Allotransplant for AML Will Need More Than Greater Access to Donors <Transplant Cell Therapy. 2026 Jun;32(6):642-643.Transplantation and cellular therapy
Temporal Trends in Real-World Outcomes With CPX-351 in Secondary/High-Risk Acute Myeloid Leukemia: A PETHEMA Study.Hematological oncology
BCLAF1 links RNA splicing to ATF4-dependent metabolic adaptation in acute myeloid leukemia.Science advances
Post-transplant maintenance in acute myeloid leukemia in Italy: results of the GITMO-maintenance survey.Leukemia & lymphoma
Clinical characteristics and outcomes of extramedullary acute myeloid leukemia: a 20-year referral center experience.International journal of hematology
Corrigendum to Treosulfan-Based Conditioning Ameliorates the Impact of Pretransplantation Measurable Residual Disease-Positivity in Acute Myeloid Leukemia Patients Allografted in Remission, Transplant and Cellular Therapy, Volume 32, Issue 3, March 2026, Pages 294.e1-294.e11).Transplantation and cellular therapy
Retraction notice to "Corrigendum to SS30, a novel thioaptamer targeting CD123, inhibits the growth of acute myeloid leukemia cells" [Life Sci. 232 (2019) 116663].Life sciences
Hyperspectral Histopathology with Spectral-Spatial Multiple-Instance Learning for Acute Leukemia Classification.Photodiagnosis and photodynamic therapy
Incremental Yield of CD34-Positive Cell Enrichment for Next-Generation Sequencing-Based Measurable Residual Disease Detection in CD34-Positive Acute Myeloid Leukemia.Annals of laboratory medicine
Improved multistate survival in younger AML patients over time.HemaSphere
Acrokeratosis Paraneoplastica (Bazex Syndrome) Uncovering Chronic Myelomonocytic Leukemia With Transformation to Acute Myeloid Leukemia.International journal of dermatology
An IHC-based apoptotic priming profile from whole-slide imaging stratifies survival in venetoclax-based AML therapy.Virchows Archiv : an international journal of pathology
LncRNA TRAF3IP2-AS1 Serves as a Potential Biomarker and Drives Acute Myeloid Leukemia Progression via miR-186-5p/EP300 Axis.International journal of laboratory hematology
Increase in fetal haemoglobin from baseline to day 10 is a biomarker for response to decitabine in AML: Results of the AML21 randomized phase III trial of the EORTC Leukemia Group, Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) and German MDS Study Group.British journal of haematology
CAR T and NK cell therapy for acute myeloid leukemia.International immunology
SPINK2 knockdown reduces proliferation and promotes cell death in MLL-MLLT3-rearranged THP-1 cells.Histochemistry and cell biology
ReviewMalignant remodeling of the bone marrow microenvironment in acute myeloid leukemia: mechanisms and therapeutic implications.Frontiers in oncology
Personalized Prediction of Venetoclax-Associated Tumor Lysis Syndrome in Acute Myeloid Leukemia Using Drug Exposure, Genetic Polymorphisms, and Clinical-Laboratory Characteristics.Drug design, development and therapy
Fear of Recurrence and Medication Adherence in Pediatric Leukaemia Survivors in Low-Resource Settings.Juntendo medical journal
Measurable Residual Disease in IDH-Mutated AML: Identifying a Clinically Relevant Threshold for IDH Mutation Monitoring.European journal of haematology
A single-cell comprehensive atlas of leukemia and its microenvironment.Cell reports
Retraction notice to "SS30, a novel thioaptamer targeting CD123, inhibits the growth of acute myeloid leukemia cells" [Life Sci. 232 (2019) 116663].Life sciences
Shwachman-Diamond syndrome: A paradigm for ribosomopathies, somatic genetic rescue, and leukemia predisposition syndrome.Seminars in hematology
STAG2 mutation predicts superior posttransplant survival in acute myeloid leukemia treated with low-intensity induction.Blood cancer journal
Prognostic Impact of FLT3-ITD Microclones in AML: An EHA AML-Specialized Working Group Study.American journal of hematology
Clinical and molecular characteristics of FLT3-ITD microclones in elderly patients with acute myeloid leukemia receiving less-intensive therapy.Leukemia
Correction to: Targeting of acute myeloid leukemia by five-gene engineered T cells expressing transgenic T-cell receptor specific to WT1, chimeric antigenic receptor specific to GM-CSF receptor, bispecific T-cell engager specific to CD33, and tEGFR suicide gene system.Immunotherapy advances
Transcriptomic Features Associated With Kinase Inhibitor Sensitivity in KMT2A-Rearranged AML.Cancer genomics & proteomics
ReviewImmune landscape and immunotherapeutic strategies for the treatment of TP53-mutated acute myeloid leukemia.Blood reviews
Case reportTherapy-related T-lymphoblastic lymphoma following acute myeloid leukemia remission with IDH2 mutation persistence.Leukemia research reports
Rectal colonization with multidrug-resistant organisms in adult acute leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective, longitudinal, single-center study.Frontiers in cellular and infection microbiology
Randomised trialEltrombopag during induction chemotherapy in older patients with newly diagnosed acute myeloid leukemia is safe and reduces platelet transfusion requirements: The EPAG-2015 French Innovative Leukemia Organization phase 2 randomized trial.Cancer
In plain wordsRead moreRead the paper on PubMedCase reportProlonged treatment-free remission after venetoclax in combination with a hypomethylating agent in acute myeloid leukemia with inv(16).Annals of hematology
[Blast morphological abnormalities in de novo acute myeloid leukemia (excluding acute promyelocytic leukemia): associations with genetic alterations and diagnostic value of pseudo-Chediak-Higashi inclusions for the t(8;21) translocation].Annales de biologie clinique
Case reportAcute Myeloid Leukemia With KAT6A::CREBBP Rearrangement: A Rare Entity With Potential Diagnostic Pitfalls.International journal of laboratory hematology
IL-6/JAK2/STAT3 axis mediates non-classical monocyte-induced Th17-like conversion of activated Tregs in acute myeloid leukemia patients.BMC cancer
Sublethal disulfide stress facilitates TLR2-dependent NLRP3 inflammasome activation and pyroptosis in leukemia cells.Cell death & disease
TCL1A polymorphism predicts AML progression in myeloid neoplasms.Blood neoplasia
Rapid proteasomal degradation of mutant feline McDonough sarcoma-like tyrosine kinase-3 overcomes inhibitor resistance mechanisms of acute myeloid leukemia cells.Leukemia
Deep learning predicts IDH1 mutation status in acute myeloid leukemia from bone marrow smears.NPJ precision oncology
Intravital Imaging of Early AML Expansion in the Mouse Calvarial Bone Marrow.Methods in molecular biology (Clifton, N.J.)
Characterization of chemoresistant cell populations improves risk stratification and therapy prediction in pediatric acute myeloid leukemia.Nature communications
Single-Cell RNA sequencing analysis of cellular heterogeneity and microenvironment-driven signaling networks in acute myeloid leukemia.Leukemia & lymphoma
Therapeutic Synergy and Immune Activation by SUMOylation Pathway Inhibition in Acute Myeloid Leukemia.Blood advances
Nanozyme-Powered Immunotherapy via Concurrent Niche Disruption and Checkpoint Blockade for Acute Myeloid Leukemia.Acta biomaterialia
ReviewSuspected Donor-derived Myeloid Neoplasia After Allogeneic HSCT: A Case-based Review of Clonal Evolution.In vivo (Athens, Greece)
CSE1L enrichment in pediatric and young adult acute myeloid leukemia reveals a ribosomal export dependency.Cell reports
Patients' preferences for accepting risks and uncertainty in AML treatments within European public health care systems: a cross-sectional study in Finland, Italy, and Germany.Leukemia & lymphoma
Identification of SLC15A3 as a shared prognostic biomarker for AML and COVID-19 via integrative bioinformatics, machine learning and Mendelian randomization.Frontiers in oncology